Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The Global Programmable Infusion Pumps and Catheters Market, by Product Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Implantable Pumps, Patient Controlled Analgesia Pumps, and Pump Accessories), by Modality (Portable and Stationary), by Application (Oncology, Pediatrics/Neonatology, Pain, Gastroenterology, Hematology, and Diabetes), by Channel Type (Single Channel and Multi-channel), by End User (Hospitals, Ambulatory Clinics, Homecare, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 8,365.3 million in 2017, and is estimated to exhibit a CAGR of 5.8% over the forecast period (2018-2026), as highlighted in a new report published by Coherent Market Insights.
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/2565
The increasing product launches by key players, coupled with therapeutic advantages such as dose monitoring, offered by programmable infusion pumps over manual counterparts are the factors that are expected to augment growth of the global programmable infusion pumps and catheters market over the forecast period. Moreover, major market players are focusing on launching new products and gaining regulatory approvals for their products, in order to strengthen their position in the global market. For instance, in 2018, Baxter International Inc., a company involved in innovative technology for medication delivery, received approval for Spectrum IQ Infusion System with Dose IQ Safety Software from the U.S. Food and Drug Administration (FDA). Spectrum IQ system is designed specifically for bi-directional electronic medical records (EMR) integration, coupled with features such as it assists in appropriate dosing of medications to the patient.
Browse 24 Market Data Tables and 33 Figures spread through 181 Pages and in-depth TOC on global programmable infusion pumps and catheters market, by Product Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Implantable Pumps, Patient Controlled Analgesia Pumps, and Pump Accessories), by Modality (Portable and Stationary), by Application (Oncology, Pediatrics/Neonatology, Pain, Gastroenterology, Hematology, and Diabetes), by Channel Type (Single Channel and Multi-Channel), by End User (Hospitals, Ambulatory Clinics, Homecare, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) – Global Forecast to 2026
To know the latest trends and insights prevalent in the global programmable infusion pumps and catheters market Press Release, click the link below: https://bit.ly/3c6AGTu
Moreover key players are focusing on strategic mergers and acquisitions, which is further expected to drive the global programmable infusion pumps and catheters market growth over the forecast period. For instance, in April 2017, BD (Becton, Dickinson and Company), a global medical technology company, acquired Caesarea Medical Electronics (CME), a global manufacturer of infusion pump systems. This acquisition expanded company’s home care, specialty applications, and ambulatory infusion portfolio.
Key Takeaways of the global programmable infusion pumps and catheters market:
- The global programmable infusion pumps and catheters market is expected to exhibit a CAGR of 8%over the forecast period. The market growth is attributed to increasing research and development activities and product launches by key players.
- Moreover, manufacturers are focused on strategic mergers and acquisitions, and raising funds for obtaining product clearance and product commercialization
- Among regions, North America is expected to hold a dominant position in the global programmable infusion pumps and catheters market over the forecast period, attributed to product launches and active research and development activities by key players in the region
- Key players operating in the global programmable infusion pumps and catheters market include ICU Medical, Inc., Smiths Group plc., Baxter International Inc., Fresenius Se & Co. KGaA, Johnson & Johnson, Medtronic plc., Becton, Dickinson and Company, Terumo Corporation, B. Braun Melsungen AG, and Moog Inc.
Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2565
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
